Administration of recombinant IL-6 to healthy volunteers or cancer patients has been shown to stimulate VP, ACTH, and cortisol secretion suggesting that peripheral IL-6 affects the HPA axis and VP secretion in human (21, 103). The gene discussed is IL6; the disease is cancer.